Description
KLOW Blend is a multi-peptide formulation combining GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg), designed for research involving cellular signaling, peptide interaction, and multi-pathway biochemical modeling.
Each component in this blend is widely studied for its role in distinct but complementary signaling systems. GHK-Cu is a copper-binding tripeptide commonly examined in research related to peptide-mediated cellular communication and structural protein pathway interactions. BPC-157 is studied for its involvement in peptide signaling and cellular response models. TB-500, a thymosin beta-4 fragment, is frequently explored in studies involving cellular migration and signaling dynamics. KPV (Lys-Pro-Val) is a peptide fragment examined in research focused on peptide signaling pathways and regulatory interactions within controlled environments.
When combined, these compounds are utilized to investigate coordinated peptide activity, signaling efficiency, and interaction between multiple pathways within a single experimental model. The addition of KPV expands the scope of research by introducing another signaling component often studied in regulatory pathway models.
KLOW Blend has been explored in studies involving:
- Multi-peptide signaling pathway interactions
- Extracellular matrix and structural protein modeling
- Cellular communication and peptide coordination
- Peptide-mediated regulatory pathway research
- Complex signaling dynamics in controlled environments
By integrating four peptides into a single formulation, KLOW Blend allows for streamlined investigation of multi-pathway interactions and expanded signaling relationships.
Each vial contains a lyophilized peptide blend consisting of GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, and KPV 10mg.
Research Use Only (RUO). Not for human or veterinary use.





Reviews
There are no reviews yet.